Insulin glargine and Ipratropium inhalation
Determining the interaction of Insulin glargine and Ipratropium inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: ipratropium
Brand name: Atrovent HFA, Atrovent
Synonyms: Ipratropium (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Ipratropium Inhalation Aerosol
- Insulin glargine-Ipratropium Inhalation Solution
- Insulin glargine-Ipratropium Inhalation, oral/nebulization
- Insulin glargine-Ipratropium nasal
- Insulin glargine-Ipratropium Nasal 0.03
- Insulin glargine-Ipratropium Nasal 0.06
- Ipratropium inhalation-Insulin Glargine (U-100) Cartridge Systems and Pens
- Ipratropium inhalation-Insulin Glargine (U-100) Vials
- Ipratropium inhalation-Insulin Glargine (U-300) Pens
- Ipratropium inhalation-Insulin glargine and lixisenatide
- Ipratropium inhalation-Insulin glargine and lixisenatide Subcutaneous
- Ipratropium inhalation-Insulin glargine, recombinant Subcutaneous